In conclusion, our findings demonstrate that OMT could effectively attenuate MPTP-induced PD by conferring DA neuroprotection and inhibiting microglial-mediated neuroinflammation through CathD-dependent inhibition of HMGB1/TLR4/NF-κB signaling pathway. Here, TLR4 is linked to Parkinson disease.